Dabigatran is a broad used new anticoagulant that recently was described to trigger pustular psoriasis. We describe a 49-year-old Caucasian male with psoriasis that after switching from warfarin to dabigatran developed acute generalised exanthematous pustulosis (AGEP). Remarkably we hypothesized a mechanism based increased lipid peroxidation via carboxilesterse-1. In conclusion, higher awareness should be used in patients with inflammatory skin manifestations that undergo new oral anticoagulants.
Dabigatran-associate Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patients undergoing Ixekizumab and its pathogenetic mechanism / K. Schrom, A. Pacifico, R.R. Conic, P.D. Pigatto, P. Malagoli, A. Morrone, R. Finelli, N.L. Bragazzi, G. Damiani. - In: DERMATOLOGIC THERAPY. - ISSN 1396-0296. - 32:5(2019 Sep), pp. e13018.1-e13018.3. [10.1111/dth.13018]
Dabigatran-associate Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patients undergoing Ixekizumab and its pathogenetic mechanism
P.D. Pigatto;G. Damiani
2019
Abstract
Dabigatran is a broad used new anticoagulant that recently was described to trigger pustular psoriasis. We describe a 49-year-old Caucasian male with psoriasis that after switching from warfarin to dabigatran developed acute generalised exanthematous pustulosis (AGEP). Remarkably we hypothesized a mechanism based increased lipid peroxidation via carboxilesterse-1. In conclusion, higher awareness should be used in patients with inflammatory skin manifestations that undergo new oral anticoagulants.File | Dimensione | Formato | |
---|---|---|---|
dth13018.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
2.01 MB
Formato
Adobe PDF
|
2.01 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Schrom_et_al-2019-Dermatologic_Therapy.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
2.01 MB
Formato
Adobe PDF
|
2.01 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.